UNSPSC 51282804: Secnidazole

This classification denotes an antiprotozoal agent with the molecular formula C7H11N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R3459K699K, chemically known as imidazole-1-ethanol, alpha,2-dimethyl-5-nitro- but generally known as secnidazole, which bears US NIH Compound Identifier 71815. European Medicines Agency schedules Secnidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10467MIG.

UNSPSC 51282804 Secnidazole, a Commodity code, represents pharmaceutical products procured by state and local health agencies through warehouse and supply contracts. The code encompasses prescription medications and related pharmaceutical supplies sourced by state departments of health, county health systems, and public health programs to support clinical operations, disease treatment protocols, and emergency medical preparedness. State and local buyers use piggyback cooperative purchasing vehicles and competitive bidding to establish multi-year supply relationships with pharmaceutical distributors and manufacturers, typically bundling multiple drug products within a single contract to leverage volume pricing and streamline procurement cycles.

Recent state and local activity centers on Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 under Invitation for Bid, covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets across a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building and a two-year initial term plus one-year renewal option. Neither opportunity is tagged to Secnidazole specifically; the code shows limited recent direct solicitation activity under its nominal scope.